EUVIMEDEUVIMED entdecken
Crossref

Expression, purification, characterization, and cytotoxic evaluation of the ML1-STxB fusion protein

Mohammad Hasan Yousefi, Hamed Afkhami, Atefeh Akbari, Hossein Honari

Archives of Microbiology · 2023

DOI: 10.1007/s00203-023-03563-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Microbiology, 2023. Verfasst von Mohammad Hasan Yousefi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Biology, Faculty of Basic Science, Imam Hossein University, Tehran, Iran. Hauptthemen laut MEDLINE: Mistletoe, Viscum album, Antineoplastic Agents, Biological Products. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted delivery of a toxin substance to cancer cells is one of the most recent cancer treatment options. Mistletoe Lectin-1 (ML1) in Viscum album L. is a Ribosome-inactivating proteins with anticancer properties. Therefore, it appears that a recombinant protein with selective permeability can be generated by fusing ML1 protein with Shiga toxin B, which can bind to Gb3 receptor that is abundantly expressed on cancer cells. In this study, we sought to produce and purify a fusion protein containing ML1 fused to STxB and evaluate its cytotoxic activities. The ML1-STxB fusion protein coding sequence was cloned into the pET28a plasmid, then was transformed into E. coli BL21-DE3 cells. Following induction of protein expression, Ni-NTA affinity chromatography was used to purify the protein. Using SDS-PAGE and western blotting, the expression and purification processes were validated. On the SkBr3 cell line, the cytotoxic effects of the recombinant proteins were evaluated. On SDS-PAGE and western blotting membrane, analysis of purified proteins revealed a band of approximately 41 kDa for rML1-STxB. Ultimately, statistical analysis demonstrated that rML1-STxB exerted significant cytotoxic effects on SkBr3 cells at 18.09 and 22.52 ng/L. The production, purification, and encapsulation of rML1-STxB fusion protein with potential cancer cell-specific toxicity were successful. However, additional research must be conducted on the cytotoxic effects of this fusion protein on other malignant cell lines and in vivo cancer models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MistletoeViscum albumAntineoplastic AgentsBiological ProductsLectinsEscherichia coliRecombinant ProteinsRecombinant Fusion Proteins

Stichwörter der Autor:innen

AnticancerE. coliFusion proteinML1-STxBSkBr3rML1-STxB

Substanzen

LectinsRecombinant ProteinsAntineoplastic AgentsBiological ProductsRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Department of Cellular and Molecular Biology, Faculty of Basic Science, Imam Hossein University, Tehran, Iran.
  • Department of Medical Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran.
  • Faculty of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran.
  • Department of Cellular and Molecular Biology, Faculty of Basic Science, Imam Hossein University, Tehran, Iran. honari.hosein@gmail.com.

Zitieren

APA

Yousefi, M. H., Afkhami, H., Akbari, A., & Honari, H. (2023). Expression, purification, characterization, and cytotoxic evaluation of the ML1-STxB fusion protein. Archives of Microbiology. https://doi.org/10.1007/s00203-023-03563-3

Vancouver

Yousefi MH, Afkhami H, Akbari A, Honari H. Expression, purification, characterization, and cytotoxic evaluation of the ML1-STxB fusion protein. Archives of Microbiology. 2023. doi:10.1007/s00203-023-03563-3

BibTeX
@article{Yousefi2023,
  author = {Yousefi, Mohammad Hasan and Afkhami, Hamed and Akbari, Atefeh and Honari, Hossein},
  title = {Expression, purification, characterization, and cytotoxic evaluation of the ML1-STxB fusion protein},
  journal = {Archives of Microbiology},
  year = {2023},
  doi = {10.1007/s00203-023-03563-3}
}
Kostenlos starten →